ELANE and chronic obstructive pulmonary disease: NE inhibitor, AZD9668, was tested in a phase IIb trial (NCT00949975) in patients with symptomatic COPD (838 patients, males or post-menopausal females between 40 and 80 years old) receiving maintenance tiotropium, a long-acting anticholinergic bronchodilator.